WHO and UNICEF Introduce Complimentary Online Course on Children’s Environmental Health
Amidst the escalating challenges posed by environmental pollution and climate change, the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) have joined forces to launch a new…
Gender Disparities Unveiled: The Core of the Worldwide Health and Care Work Crisis, According to WHO Report
The latest publication from the World Health Organization (WHO), titled “Equity in Health and Care: Gender Dynamics in Undervalued Health and Care Labor,” sheds light on how gender disparities within…
Ionis Reports Encouraging Findings from Phase 2 Trial of ION224, Showing Clinical Effectiveness in NASH/MASH Treatment
Ionis has unveiled encouraging outcomes from its Phase 2 investigation of ION224, a DGAT2 antisense inhibitor aimed at addressing metabolic dysfunction-associated steatohepatitis (MASH), previously termed nonalcoholic steatohepatitis (NASH). The study,…
Lupin Receives Approval from U.S. FDA for Doxycycline for Injection USP
Lupin Limited, a global pharmaceutical powerhouse, has secured approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application concerning Doxycycline for Injection USP,…
The Chemical Quality Control Laboratory: Guardian of Standards in the Pharmaceutical Plant
The Role of Quality Control at Orion Pharmaceuticals Maija Blomquist, the Quality Control Manager for Materials, Gels & Ointments, underscores the pivotal role of quality control in maintaining Orion’s product…
Optimizing Project Management for Pharmaceutical Manufacturing: A Roadmap to Effective Clinical Trials
Unlocking Project Management’s Role in CDMOs In the intricate web of pharmaceutical and biotech industries, Contract Development and Manufacturing Organizations (CDMOs) stand as pivotal partners, offering indispensable services like API…
Blueprint Medicines Unveils Inducement Grants in Accordance with Nasdaq Listing Rule 5635
Blueprint Medicines Corporation (Nasdaq: BPMC) has announced that as of March 1, 2024, the Compensation Committee of its Board of Directors has approved the granting of non-qualified stock options to…
CRISPR Therapeutics Nominates Addition to Board of Directors
CRISPR Therapeutics, a leading biopharmaceutical firm dedicated to pioneering gene-based treatments for severe illnesses, has unveiled its proposal to appoint Christian Rommel, Ph.D., to its Board of Directors during the…
Bimekizumab Phase 3: Sustained Improvements in Hidradenitis Suppurativa
UCB, a global biopharmaceutical company, has unveiled the findings of 48-week post-hoc analyses derived from pooled Phase 3 data originating from the BE HEARD I and BE HEARD II trials.…
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Amgen Unveils New Research on Otezla® (Apremilast) at AAD 2024 Amgen, a leader in biotechnology, has disclosed fresh findings from the Phase 3 SPROUT trial, investigating Otezla® (apremilast) in children…
Wegovy® Approved in US to Lower Cardiovascular Risk in Overweight or Obese Individuals with Existing Heart Conditions
Novo Nordisk has announced today that the US Food and Drug Administration (FDA) has granted approval for an expanded label for Wegovy®. This approval, based on a supplemental New Drug…
A First-of-Its-Kind Study Shows Skin Improvement in Over Two-Thirds of People with Atopic Dermatitis and Skin of Color Using Lebrikizumab
Eli Lilly and Company (NYSE: LLY) has disclosed findings from a pioneering investigation into lebrikizumab, tailored specifically for individuals with skin of color grappling with moderate-to-severe atopic dermatitis, commonly known…